Literature DB >> 15258452

Topical activity of ascorbic acid: from in vitro optimization to in vivo efficacy.

T Raschke1, U Koop, H-J Düsing, A Filbry, K Sauermann, S Jaspers, H Wenck, K-P Wittern.   

Abstract

We present here a new cosmetic formula system containing 3% ascorbic acid based on an optimized oil-in-water (O/W) emulsion. This formulation demonstrated a good long-term stability of the active ingredient and also of the emulsion itself. It could be deduced from in vitro release studies that this O/W emulsion enabled a better release of the hydrophilic active agent than an alternative W/O emulsion. By measuring the ultraweak photon emission, which is a well-established parameter for the oxidative stress in the skin, the high in vivo antioxidant capacity of 3% ascorbic acid was demonstrated after 1 week of product application. This placebo-controlled study also proved that ascorbic acid in an O/W cream reduced oxidative stress in human skin significantly better than the derivative sodium ascorbyl-2-phosphate, a more stable vitamin C replacement commonly used in cosmetic formulations. With increasing age, the number of papillae in the epidermal-dermal junction zone in human skin are reduced. This implies a possible consequence of reduced mechanical resistance of the skin and impaired supply of the epidermis with nutrients. In a 1-month placebo-controlled study on 25 human volunteers, a significant increase in the number of dermal papillae after application of the 3% ascorbic acid cream was demonstrated, using a confocal laser scanning microscope. Fine lines and wrinkles are a characteristic sign of aged and especially photo-aged skin. Application of 3% ascorbic acid in a 12-week placebo-controlled usage study indicated a significant reduction of facial wrinkles. Altogether, 3% ascorbic acid in a cosmetic O/W emulsion has been shown to be appropriately stable and to enable a good release of the active agent in vitro as a precondition for a high efficacy in vivo. Application in vivo resulted in a significant reduction of oxidative stress in the skin, an improvement of the epidermal-dermal microstructure and a reduction of fine lines and wrinkles in aged skin. These results were received within a relatively short period of time of product application.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15258452     DOI: 10.1159/000078824

Source DB:  PubMed          Journal:  Skin Pharmacol Physiol        ISSN: 1660-5527            Impact factor:   3.479


  7 in total

1.  Photostability and interaction of ascorbic acid in cream formulations.

Authors:  Iqbal Ahmad; Muhammad Ali Sheraz; Sofia Ahmed; Riaz Hussain Shaikh; Faiyaz H M Vaid; Saif ur Rehman Khattak; Shakeel A Ansari
Journal:  AAPS PharmSciTech       Date:  2011-07-07       Impact factor: 3.246

Review 2.  Cosmeceuticals: the new medicine of beauty.

Authors:  Katherine I Martin; Dee Anna Glaser
Journal:  Mo Med       Date:  2011 Jan-Feb

3.  Topically applied vitamin C increases the density of dermal papillae in aged human skin.

Authors:  Kirsten Sauermann; Sören Jaspers; Urte Koop; Horst Wenck
Journal:  BMC Dermatol       Date:  2004-09-29

Review 4.  Ultraweak photon emission as a non-invasive health assessment: a systematic review.

Authors:  John A Ives; Eduard P A van Wijk; Namuun Bat; Cindy Crawford; Avi Walter; Wayne B Jonas; Roeland van Wijk; Jan van der Greef
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

Review 5.  Ultraviolet radiation, aging and the skin: prevention of damage by topical cAMP manipulation.

Authors:  Alexandra Amaro-Ortiz; Betty Yan; John A D'Orazio
Journal:  Molecules       Date:  2014-05-15       Impact factor: 4.411

6.  A novel skin brightening topical technology.

Authors:  Zoe Diana Draelos; Isabel Diaz; Aaron Cohen; Junhong Mao; Thomas Boyd
Journal:  J Cosmet Dermatol       Date:  2020-10-12       Impact factor: 2.696

Review 7.  Plant-Derived Antioxidants: Significance in Skin Health and the Ageing Process.

Authors:  Monika Michalak
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.